We are live on ! Find out more
GS

GTS Securities Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.76%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+21.76%
3 Year Est. Return
+68.93%
5 Year Est. Return
10 Year Est. Return
AUM
$46B
AUM Growth
-$945M
Cap. Flow
-$2.64B
Cap. Flow %
-5.74%
Top 10 Hldgs %
38.54%
Holding
4,570
New
696
Increased
1,653
Reduced
1,646
Closed
543

Sector Composition

Rank Sector Weight
1 Technology 2.2%
2 Consumer Discretionary 1.38%
3 Communication Services 0.71%
4 Healthcare 0.57%
5 Financials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TELL
3951
DELISTED
Tellurian Inc.
TELL
$22.6K ﹤0.01%
+23,320
New +$20.2K
WW
3952
PUT
DELISTED
WW International
WW
$22.3K ﹤0.01%
25,400
+9,100
+56% +$8.83K
REI icon
3953
CALL
Ring Energy
REI
$320M
$22.2K ﹤0.01%
13,900
-200
-1% -$358
AKBA icon
3954
CALL
Akebia Therapeutics
AKBA
$354M
$21.8K ﹤0.01%
16,500
-13,700
-45% -$18.3K
FCEL icon
3955
PUT
FuelCell Energy
FCEL
$1.8B
$20.9K ﹤0.01%
1,837
-200
-10% -$2.96K
TMC icon
3956
PUT
TMC The Metals Company
TMC
$1.71B
$20.8K ﹤0.01%
19,600
+1,900
+11% +$2.12K
DNN icon
3957
CALL
Denison Mines
DNN
$2.7B
$20.5K ﹤0.01%
11,200
-426,400
-97% -$749K
AMRN
3958
Amarin Corp
AMRN
$302M
$20.3K ﹤0.01%
1,620
-1,035
-39% -$13.7K
CCO icon
3959
Clear Channel Outdoor Holdings
CCO
$1.24B
$18.3K ﹤0.01%
+11,426
New +$17.9K
ALXO icon
3960
CALL
ALX Oncology
ALXO
$265M
$18.2K ﹤0.01%
+10,000
New +$37.2K
ESPR
3961
CALL
DELISTED
Esperion Therapeutics
ESPR
$17.7K ﹤0.01%
10,700
-40,900
-79% -$82.6K
CMRX
3962
CALL
DELISTED
Chimerix, Inc.
CMRX
$17.5K ﹤0.01%
18,800
-5,300
-22% -$4.73K
CHPT icon
3963
ChargePoint
CHPT
$152M
$17K ﹤0.01%
+622
New +$21.6K
BLUE
3964
PUT
DELISTED
bluebird bio
BLUE
$16.9K ﹤0.01%
1,625
-1,565
-49% -$26K
VUZI icon
3965
CALL
Vuzix
VUZI
$220M
$16K ﹤0.01%
13,700
-13,800
-50% -$15K
INVZ icon
3966
Innoviz Technologies
INVZ
$92.4M
$15.7K ﹤0.01%
19,009
-18,548
-49% -$14.1K
ANY icon
3967
Sphere 3D
ANY
$17.3M
$15.6K ﹤0.01%
1,726
+722
+72% +$6.88K
LPSN icon
3968
CALL
LivePerson
LPSN
$27M
$15.4K ﹤0.01%
800
-393
-33% -$6.66K
BLUE
3969
CALL
DELISTED
bluebird bio
BLUE
$14K ﹤0.01%
1,350
-960
-42% -$16K
OTLY
3970
PUT
Oatly Group
OTLY
$461M
$14K ﹤0.01%
820
-315
-28% -$5.92K
NEGG icon
3971
Newegg Commerce
NEGG
$321M
$14K ﹤0.01%
946
+404
+75% +$6.91K
LAZR
3972
DELISTED
Luminar Technologies
LAZR
$13.9K ﹤0.01%
+1,028
New +$18.7K
TLSIW icon
3973
TriSalus Life Sciences Warrant
TLSIW
$27.9M
$13.8K ﹤0.01%
+13,132
New +$17.7K
AREC icon
3974
American Resources Corp
AREC
$217M
$13.8K ﹤0.01%
15,117
+220
+1% +$133
IAUX
3975
i-80 Gold Corp
IAUX
$1.21B
$13.4K ﹤0.01%
+11,516
New +$12.1K

Similar funds

GTS Securities's Q3 2024 Portfolio in Review

As of Q3 2024, GTS Securities held 4,570 positions worth $46B, down 2% from $46.9B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

GTS Securities withdrew a net $2.64B in Q3 2024, closing 543 positions and reducing 1,646 holdings. Its most notable exit was ProShares UltraPro Short QQQ, an estimated $33.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.2% of assets, down from 2.2% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, GTS Securities opened a new position in ProShares UltraPro QQQ worth $23.2M.

  • GTS Securities's largest Q3 2024 buy was ProShares UltraPro QQQ: 640,308 shares worth $23.2M.
  • GTS Securities added most to Microsoft in Q3 2024, an estimated $112M increase.
  • GTS Securities's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $141M.
  • GTS Securities fully exited ProShares UltraPro Short QQQ in Q3 2024, selling an estimated $33.4M.
  • GTS Securities's ten largest holdings make up 39% of its $46B portfolio in Q3 2024.
  • GTS Securities opened 696 new positions and closed 543 in Q3 2024.
  • GTS Securities's portfolio value fell 2% quarter-over-quarter to $46B.

Based on GTS Securities's 13F filing for Q3 2024, filed 13 Nov 2024.